Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Neurooncol. 2017 Jan 23;132(1):181–188. doi: 10.1007/s11060-016-2357-9

Table 3B. Grade 3 and 4 toxicities attributed to aflibercept and temozolomide for Arm 2.

Adverse Event Aflibercept DL0 Aflibercept DL1 Temozolomide (DL0) Temozolomide (DL1)
Biliary anastomotic leak 1
Aspartate aminotransferase increase 1
Cholecystitis 1 1
Diarrhea 1
Fatigue 1 1
Dysphasia 1
Hypertension 5 2
Hyponatremia 1 1
Palmar-plantar erythrodysesthesia syndrome 1
Thromboembolic event 1
Leukopenia 2 2
Lymphopenia 4 4
Neutropenia 2 1 2
Thrombocytopenia 2 3